BusinessCORRECTION: CEO, Brady Granier, From BioCorRx® Inc. Discusses Upcoming FDA Meeting on “Stock Day” Podcast; Aims to Fight Opioid CrisisBy Nasdaq OMXJan 22, 2018, 3:55 PM UTC
BusinessCEO, Brady Grainer, From BioCorRx®Inc. Paves Pathway Towards Possible FDA Approval on “Stock Day” Podcast; Aims to Fight Opioid CrisisBy Nasdaq OMXJan 22, 2018, 12:00 PM UTC